RT Journal Article SR Electronic T1 Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies JF Journal of Nuclear Medicine JO J Nucl Med FD Society of Nuclear Medicine SP 1718 OP 1726 DO 10.2967/jnumed.116.186361 VO 58 IS 11 A1 Bodei, Lisa A1 Ambrosini, Valentina A1 Herrmann, Ken A1 Modlin, Irvin YR 2017 UL http://jnm.snmjournals.org/content/58/11/1718.abstract AB 68Ga-DOTATATE PET/CT provides information on the location of somatostatin receptor–expressing tumors. Integrating this imaging data effectively in patient care requires the clinical history; the histopathology and biomarker information; and the grade, stage, and prior imaging results. Previous therapies and technical aspects of the study should be considered, given their ability to alter the interpretation of the images. This includes physiologic biodistribution of the radiotracer, as well as conditions that engender false-positive results. This article provides a guide to the performance and interpretation of 68Ga-DOTATATE PET/CT and describes its role in the diagnostic algorithm of neuroendocrine neoplasms and its overall utility in their management.